reduotase inhibitor products / Prostate Cancer Prevention / /
MedicalCondition
pmstate cancer / ofhigh-grade prostate cancer / BPH / cancer / benign prostatic hyperplasia / prostate cancer / /
Organization
Regisfation Committee of the Pharmacy / Ad.verse Drug Reaotion Monitoring Unit / Public Heelth Labor8tory Centre / Dept of Health / Department of Health / Pharmaceutical Service / P.8t DEPARTMENT OF HEALTH PHARMACEUTICALS REGISTRATION $ECTION ffip/iIffiiB / U.S. Food and Drug Administration / Raymond LIANG Presidont Hong Kong Academy of Medicine / Pharmacy and Poisons Board / / /